Skip to content
PubMed This is a summary of 74 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 74 referenced papers

Top Authors

P. James B. Dyck
Mayo Clinic
Alfonso José Cruz-Jentoft
Instituto Ramón y Cajal de Investigación Sanitaria
Hidenori Arai
National Center for Geriatrics and Gerontology
Francesco Landi
Università Cattolica del Sacro Cuore
Andrew Lee Mammen
National Institutes of Health
Tommy Cederholm
Uppsala University
Matteo Cesari
University of Milan
Jean Woo
Chinese University of Hong Kong
Cornel Christian Sieber
Friedrich-Alexander-Universität Erlangen-Nürnberg

Top Institutions

Ranked by publications Top 10 institutions
08

University of Kansas Medical Center

Kansas City, United States

6 papers
10

Instituto Ramón y Cajal de Investigación Sanitaria

Madrid, Spain

28 papers

References

References (74)
  1. 1

    Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.

    Stroes ES, Thompson PD, Corsini A, et al.

    European heart journal 2015; (36(17)):1012-22 doi:10.1093/eurheartj/ehv043.

    PMID: 25694464
  2. 2

    Diabetic muscle infarction: a systematic review.

    Horton WB, Taylor JS, Ragland TJ, Subauste AR

    BMJ open diabetes research & care 2015; (3(1)):e000082 doi:10.1136/bmjdrc-2015-000082.

    PMID: 25932331
  3. 3

    Spontaneous diabetic myonecrosis: report of four cases from a tertiary care institute.

    Mukherjee S, Aggarwal A, Rastogi A, et al.

    Endocrinology, diabetes & metabolism case reports 2015; (2015()):150003 doi:10.1530/EDM-15-0003.

    PMID: 26124952
  4. 4

    Dietary Protein to Maintain Muscle Mass in Aging: A Case for Per-meal Protein Recommendations.

    Murphy CH, Oikawa SY, Phillips SM

    The Journal of frailty & aging 2016; (5(1)):49-58 doi:10.14283/jfa.2016.80.

    PMID: 26980369
  5. 5

    Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy.

    Floyd JS, Brody JA, Tiniakou E, et al.

    Muscle & nerve 2016; (54(1)):142-4 doi:10.1002/mus.25127.

    PMID: 27038110
  6. 6

    Resistance Exercise to Prevent and Manage Sarcopenia and Dynapenia.

    Law TD, Clark LA, Clark BC

    Annual review of gerontology & geriatrics 2016; (36(1)):205-228 doi:10.1891/0198-8794.36.205.

    PMID: 27134329
  7. 7

    Recurrent Diabetic Muscle Infarction Affecting Bilateral Thighs: Uncommon Presentation with Grave Prognosis.

    Horton WB, Tripathi A, Ragland TJ, Yousuf T

    Journal of the Mississippi State Medical Association 2016; (57(2)):39-42.

    PMID: 27141766
  8. 8

    Diabetic Myonecrosis: A Rare Complication of Diabetes Mellitus Mimicking Deep Vein Thrombosis.

    Khanna HK, Stevens AC

    The American journal of case reports 2017; (18()):38-41 doi:10.12659/ajcr.900903.

    PMID: 28074044
  9. 9

    Statin-associated immune-mediated myopathy: biology and clinical implications.

    Christopher-Stine L, Basharat P

    Current opinion in lipidology 2017; (28(2)):186-192 doi:10.1097/MOL.0000000000000399.

    PMID: 28207435
  10. 10

    Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases.

    Nazir S, Lohani S, Tachamo N, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2017; (23(3)):149-154 doi:10.1097/RHU.0000000000000497.

    PMID: 28277343
  11. 11

    Diabetic Myopathy: current molecular understanding of this novel neuromuscular disorder.

    Monaco CMF, Perry CGR, Hawke TJ

    Current opinion in neurology 2017; (30(5)):545-552 doi:10.1097/WCO.0000000000000479.

    PMID: 28665810
  12. 12

    Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients.

    Annibalini G, Lucertini F, Agostini D, et al.

    Oxidative medicine and cellular longevity 2017; (2017()):3937842 doi:10.1155/2017/3937842.

    PMID: 28713486
  13. 13

    Immunotherapy for diabetic amyotrophy.

    Chan YC, Lo YL, Chan ES

    The Cochrane database of systematic reviews 2017; (7()):CD006521 doi:10.1002/14651858.CD006521.pub4.

    PMID: 28746752
  14. 14

    Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

    Selva-O'Callaghan A, Alvarado-Cardenas M, Pinal-Fernández I, et al.

    Expert review of clinical immunology 2018; (14(3)):215-224 doi:10.1080/1744666X.2018.1440206.

    PMID: 29473763
  15. 15

    Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment.

    Yong TY, Khow KSF

    World journal of nephrology 2018; (7(2)):58-64 doi:10.5527/wjn.v7.i2.58.

    PMID: 29527509
  16. 16

    Use of MRI in diabetic lumbosacral radiculoplexus neuropathy: case report and review of the literature.

    McCormack EP, Alam M, Erickson NJ, et al.

    Acta neurochirurgica 2018; (160(11)):2225-2227 doi:10.1007/s00701-018-3664-z.

    PMID: 30203363
  17. 17

    Sarcopenia: revised European consensus on definition and diagnosis.

    Cruz-Jentoft AJ, Bahat G, Bauer J, et al.

    Age and ageing 2019; (48(1)):16-31 doi:10.1093/ageing/afy169.

    PMID: 30312372
  18. 18

    Hyperglycaemia correlates with skeletal muscle capillary regression and is associated with alterations in the murine double minute-2/forkhead box O1/thrombospondin-1 pathway in type 1 diabetic BioBreeding rats.

    Aiken J, Mandel ER, Riddell MC, Birot O

    Diabetes & vascular disease research 2019; (16(1)):28-37 doi:10.1177/1479164118805928.

    PMID: 30360646
  19. 19

    [Lumbosacral radiculoplexus neuropathy with a small intramedullary lesion in posterior spinal cord: a case report].

    Arai M

    Rinsho shinkeigaku = Clinical neurology 2018; (58(12)):745-749 doi:10.5692/clinicalneurol.cn-001213.

    PMID: 30487361
  20. 20

    International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

    Dent E, Morley JE, Cruz-Jentoft AJ, et al.

    The journal of nutrition, health & aging 2018; (22(10)):1148-1161 doi:10.1007/s12603-018-1139-9.

    PMID: 30498820
  21. 21

    Diabetic amyotrophy: a painful radiculoplexus neuropathy.

    Llewelyn D, Llewelyn JG

    Practical neurology 2019; (19(2)):164-167 doi:10.1136/practneurol-2018-002105.

    PMID: 30530723
  22. 22

    Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes.

    Mori H, Kuroda A, Ishizu M, et al.

    Journal of diabetes investigation 2019; (10(5)):1332-1340 doi:10.1111/jdi.13014.

    PMID: 30677242
  23. 23

    Statins, myalgia, and rhabdomyolysis.

    Tournadre A

    Joint bone spine 2020; (87(1)):37-42 doi:10.1016/j.jbspin.2019.01.018.

    PMID: 30735805
  24. 24

    Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus.

    Ogama N, Sakurai T, Kawashima S, et al.

    Journal of clinical medicine 2019; (8(3)) doi:10.3390/jcm8030319.

    PMID: 30845785
  25. 25

    Quantitative assessment of diabetic amyotrophy using magnetic resonance neurography-a case-control analysis.

    Hlis R, Poh F, Bryarly M, et al.

    European radiology 2019; (29(11)):5910-5919 doi:10.1007/s00330-019-06162-3.

    PMID: 30980123
  26. 26

    MUSCLE INFARCTION AND SEVERE DETERIORATION OF RENAL FUNCTION IN A PATIENT WITH TYPE 1 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE.

    Sánchez-Hernández RM, Alberiche-Ruano MP, López-Plasencia Y, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2016; (12(2)):224-226 doi:10.4183/aeb.2016.224.

    PMID: 31149091
  27. 27

    Diagnostic Tools for Sarcopenia: Can We Get Less Expensive and Accurate Methods?

    Setiati S

    Acta medica Indonesiana 2019; (51(2)):93-94.

    PMID: 31383822
  28. 28

    Upper-Limb Diabetic Myonecrosis: Atypical Presentation of a Rare Complication.

    Jalali Z, Sharif SK

    The American journal of case reports 2019; (20()):1268-1272 doi:10.12659/AJCR.917030.

    PMID: 31455756
  29. 29

    [Bruns Garland syndrome. Report of a case and differential diagnosis with cauda equina syndrome].

    Jiménez-Ávila JM, Castañeda-Huerta JE, González-Cisneros AC

    Acta ortopedica mexicana 2019; (33(1)):42-45.

    PMID: 31480126
  30. 30

    Statin-induced necrotizing autoimmune myopathy: An uncommon complication of a commonly used medication.

    Saleh Y, Herzallah K, Hassanein M, Chang HT

    Journal of the Saudi Heart Association 2019; (31(4)):269-272 doi:10.1016/j.jsha.2019.08.001.

    PMID: 31516306
  31. 31

    Diabetic amyotrophy, not your typical back pain.

    Na JSD, Dittmar PC

    BMJ case reports 2020; (13(1)) doi:10.1136/bcr-2019-231928.

    PMID: 31924707
  32. 32

    Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.

    Chen LK, Woo J, Assantachai P, et al.

    Journal of the American Medical Directors Association 2020; (21(3)):300-307.e2 doi:10.1016/j.jamda.2019.12.012.

    PMID: 32033882
  33. 33

    Diabetic myonecrosis: an uncommon diabetic complication.

    Kempegowda P, Melson E, Langman G, et al.

    Endocrinology, diabetes & metabolism case reports 2019; (2019(1)):1-4.

    PMID: 32677424
  34. 34

    Diabetic Lumbosacral Radiculoplexus Neuropathy (Diabetic Amyotrophy).

    Glenn MD, Jabari D

    Neurologic clinics 2020; (38(3)):553-564 doi:10.1016/j.ncl.2020.03.010.

    PMID: 32703468
  35. 35

    Applications of physical performance measures to routine diabetes care for frailty prevention concept: fundamental data with grip strength, gait speed, timed chair stand speed, standing balance, and knee extension strength.

    Yokoyama H, Shiraiwa T, Takahara M, et al.

    BMJ open diabetes research & care 2020; (8(1)) doi:10.1136/bmjdrc-2020-001562.

    PMID: 32948539
  36. 36

    Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.

    Casula M, Gazzotti M, Bonaiti F, et al.

    Journal of internal medicine 2021; (290(1)):116-128 doi:10.1111/joim.13219.

    PMID: 33259671
  37. 37

    Statin-Associated Myalgias and Muscle Injury-Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein.

    Mammen AL

    The Medical clinics of North America 2021; (105(2)):263-272 doi:10.1016/j.mcna.2020.10.004.

    PMID: 33589101
  38. 38

    Lumbosacral Radiculoplexus Neuropathy: Neurologic Outcomes and Survival in a Population-Based Study.

    Pinto MV, Ng PS, Howe BM, et al.

    Neurology 2021; (96(16)):e2098-e2108 doi:10.1212/WNL.0000000000011799.

    PMID: 33653898
  39. 39

    Challenges in Treating Statin-Associated Necrotizing Myopathy.

    Webster P, Wiemer N, Al Harash A, et al.

    Case reports in rheumatology 2021; (2021()):8810754 doi:10.1155/2021/8810754.

    PMID: 33708450
  40. 40

    Diabetic Muscle Infarction: Resolution of Rare Microangiopathy with Over-The-Counter Medication.

    Jariwal R, Raza N, Cadang C, et al.

    Case reports in medicine 2021; (2021()):5555051 doi:10.1155/2021/5555051.

    PMID: 34335786
  41. 41

    Muscle Infarction Following Rapid Glycemic Control in a Patient With Diabetes-Associated Microvascular Disease.

    Boavida L, Carvalho J, Oliveira S, Delgado Alves J

    Cureus 2021; (13(8)):e17182 doi:10.7759/cureus.17182.

    PMID: 34540416
  42. 42

    Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual-energy X-ray absorptiometry.

    Cheng KY, Chow SK, Hung VW, et al.

    Journal of cachexia, sarcopenia and muscle 2021; (12(6)):2163-2173 doi:10.1002/jcsm.12825.

    PMID: 34609065
  43. 43

    [Two cases of statin-induced immune-mediated necrotizing myopathy].

    Safi T, Wagner H

    Lakartidningen 2021; (118()).

    PMID: 34861042
  44. 44

    Diabetic sarcopenia: metabolic and molecular appraisal.

    Giha HA, Alamin OAO, Sater MS

    Acta diabetologica 2022; (59(8)):989-1000 doi:10.1007/s00592-022-01883-2.

    PMID: 35429264
  45. 45

    Rehabilitation of Individuals With Diabetes Mellitus: Focus on Diabetic Myopathy.

    Bassi-Dibai D, Santos-de-Araújo AD, Dibai-Filho AV, et al.

    Frontiers in endocrinology 2022; (13()):869921 doi:10.3389/fendo.2022.869921.

    PMID: 35498435
  46. 46

    Diabetic Mononeuropathies and Diabetic Amyotrophy.

    Bell DSH

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2022; (13(10)):1715-1722 doi:10.1007/s13300-022-01308-x.

    PMID: 35969368
  47. 47

    Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.

    Warden BA, Guyton JR, Kovacs AC, et al.

    Journal of clinical lipidology 2023; (17(1)):19-39 doi:10.1016/j.jacl.2022.09.001.

    PMID: 36115813
  48. 48

    Correlation between lipoprotein(a), albuminuria, myostatin and sarcopenia in elderly patients with type 2 diabetes.

    Li X, Kong X, Li R

    Journal of diabetes and its complications 2023; (37(1)):108382 doi:10.1016/j.jdiacomp.2022.108382.

    PMID: 36535110
  49. 49

    Diabetic Amyotrophy (Bruns-Garland Syndrome): A Narrative Review.

    Agarwal A, Srivastava MVP, Vishnu VY

    Annals of Indian Academy of Neurology 2022; (25(5)):841-844 doi:10.4103/aian.aian_239_22.

    PMID: 36561022
  50. 50

    Lumbosacral Radiculoplexus Neuropathy After COVID-19.

    Aragon Pinto C, Pinto MV, Engelstad JK, Dyck PJB

    The neurologist 2023; (28(4)):273-276 doi:10.1097/NRL.0000000000000481.

    PMID: 36728648
  51. 51

    Diabetic myonecrosis: An easily overlooked cause of limb pain in diabetic patients.

    Wells J, Sorsby SC

    Journal of the American Association of Nurse Practitioners 2024; (36(3)):194-196 doi:10.1097/JXX.0000000000000962.

    PMID: 37882690
  52. 52

    Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes : Expert document.

    de Luis Román D, Gómez JC, García-Almeida JM, et al.

    Reviews in endocrine & metabolic disorders 2024; (25(4)):651-661 doi:10.1007/s11154-023-09871-9.

    PMID: 38315411
  53. 53

    Bruns Garland Syndrome as the first presentation of type 2 diabetes: two case reports and a practical approach to diagnosis.

    Ambawatte S, Wijewickrama P, Gunarathne K, Somasundaram N

    Journal of medical case reports 2024; (18(1)):99 doi:10.1186/s13256-023-04327-9.

    PMID: 38360756
  54. 54

    Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus.

    Belfield AE, Wilkinson TJ, Henson J, et al.

    Age and ageing 2024; (53(5)) doi:10.1093/ageing/afae090.

    PMID: 38706394
  55. 55

    Diabetic myonecrosis complicated by emphysematous pyomyositis and abscess caused by Escherichia coli: a case report.

    Kerola AM, Eklund KK, Valleala H, et al.

    Journal of medical case reports 2024; (18(1)):300 doi:10.1186/s13256-024-04614-z.

    PMID: 38946001
  56. 56

    Physiological mechanisms of neuromuscular impairment in diabetes-related complications: Can physical exercise help prevent it?

    Lecce E, Bellini A, Greco G, et al.

    The Journal of physiology 2026; (604(2)):707-734 doi:10.1113/JP287589.

    PMID: 39898972
  57. 57

    Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?

    Al-Awadi AA, Gray SR, Al-Ozairi E

    Reviews in endocrine & metabolic disorders 2025; (26(5)):857-870 doi:10.1007/s11154-025-09947-8.

    PMID: 39998784
  58. 58

    The Asia-Oceania consensus: Definitions and diagnostic criteria for sarcopenic obesity.

    Chen TP, Kao HH, Ogawa W, et al.

    Obesity research & clinical practice 2025; (19(3)):185-192 doi:10.1016/j.orcp.2025.05.001.

    PMID: 40335420
  59. 59

    A comparative analysis of sarcopenia screening methods in Thai people with type 2 diabetes mellitus in an outpatient setting.

    Laohajaroensombat O, Limpaarayakul T, Sathavarodom N, et al.

    BMC geriatrics 2025; (25(1)):346 doi:10.1186/s12877-025-06020-6.

    PMID: 40380097
  60. 60

    Insights into Diabetes Muscle Infarction: Clinical Characteristics and Outcome.

    Singhal V, Meyyappan J, Jain N, et al.

    Neurology India 2025; (73(3)):500-505 doi:10.4103/neurol-india.Neurol-India-D-23-00672.

    PMID: 40408578
  61. 61

    GLP-1RA-Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies: A Case-Control Evaluation.

    Triplett JD, Pinto MV, Young NP, et al.

    Neurology 2025; (105(3)):e213916 doi:10.1212/WNL.0000000000213916.

    PMID: 40694751
  62. 62

    Diagnosis and Management of Statin-Associated Muscle Symptoms.

    Cha JJ, Hong SJ

    Korean circulation journal 2025; (55(11)):957-968 doi:10.4070/kcj.2025.0285.

    PMID: 41044735
  63. 63

    Diabetic Neuropathy Part 2: Proximal and Asymmetric Phenotypes.

    Davalos L, Pasnoor M, Dimachkie MM, Barohn RJ

    Neurologic clinics 2025; (43(4)):693-710 doi:10.1016/j.ncl.2025.05.007.

    PMID: 41161991
  64. 64

    A Rare Complication of Diabetes Mellitus: Bruns-Garland Syndrome (Diabetic Amyotrophy).

    Demir F, Akıl E

    Journal of clinical practice and research 2023; (45(6)):644-647 doi:10.14744/cpr.2023.88598.

    PMID: 41256745
  65. 65

    The Role of Caudal Epidural Steroid Injections in Diabetic Lumbosacral Radiculoplexus Neuropathy: A Case Report.

    Roys J, Catalanatto M, Vangeison C, Husu EN

    Pain medicine case reports 2022; (6(7)):267-269.

    PMID: 41299949
  66. 66

    Diabetic lumbosacral radiculoplexus neuropathy after glucagon-like peptide 1 receptor agonist use: A case series.

    Chandrashekhar S, Davalos L, Pradhan R, Paul P

    Journal of the neurological sciences 2026; (481()):125755 doi:10.1016/j.jns.2026.125755.

    PMID: 41534440
  67. 67

    Revisiting Diabetic Myonecrosis: A Case Report Highlighting Diagnostic and Management Challenges.

    Sabir DM, Elaziz M, Nayyar SM, et al.

    Cureus 2026; (18(5)):e109268 doi:10.7759/cureus.109268.

    PMID: 42326229
  68. 68

    Statin-Associated Muscle Symptoms and Myotoxicity: A Clinically Oriented Narrative Review with a Practical Prevention, Evaluation, and Management Algorithm.

    Epelde F

    Medicina (Kaunas, Lithuania) 2026; (62(6)) doi:10.3390/medicina62061134.

    PMID: 42356146
  69. 69

    Glycemic variability and muscle loss in elderly type 2 diabetes: insights from continuous glucose monitoring and chest CT in 303 patients.

    Zhang XL, Bai N, Mao CP, Liu CY

    Frontiers in endocrinology 2026; (17()):1863226 doi:10.3389/fendo.2026.1863226.

    PMID: 42440574
  70. 70

    Severe Rosuvastatin-Associated Myopathy With Persistent HyperCKemia and Transaminitis: Early Outpatient Recognition and Diagnostic Pitfalls.

    Bhatti HA

    Cureus 2026; (18(7)):e113256 doi:10.7759/cureus.113256.

    PMID: 42634640
  71. 71

    Diabetic Myonecrosis: An Under-Recognised Complication of Poorly Controlled Diabetes with a High Morbidity- A Clinico-Radiological Study.

    Kumar V, Hussain MA, Kurian ME, et al.

    Indian journal of endocrinology and metabolism 2026; (30(4)):313-319 doi:10.4103/ijem.ijem_1078_25.

    PMID: 42788116
  72. 72

    Persistent HyperCKemia Beyond Post-Viral Myositis: A Case of Anti-HMGCR Immune-Mediated Necrotizing Myopathy.

    Xavier R, Silva S, Cunha R, et al.

    Cureus 2026; (18(9)):e116203 doi:10.7759/cureus.116203.

    PMID: 42877551
  73. 73

    Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework.

    Zhang J, Zhai X, Sha S, Zhang L

    Drugs 2026; doi:10.1007/s40265-026-02408-9.

    PMID: 42892668
  74. 74

    Severe Rhabdomyolysis With Minimal Muscular Symptoms After Long-Term Rosuvastatin Use: A Case Report and Brief Literature Review.

    Izadian Bidgoli A, Gomez Usatorres A, Gomez Usatorres HA, et al.

    Cureus 2026; (18(10)):e117283 doi:10.7759/cureus.117283.

    PMID: 42967085